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ABSTRACT  
Background: Pain is a frequently reported symptom by patients approaching the end of life and well-
established that patients and carers hold fears relating to opioids, and experience side effects related 
to their use. The management of medicines is intrinsic to achieving effective pain relief. The concept 
of self-management support whilst well characterised in the context of chronic illness has not been 
elaborated with respect to end of life care. 
Aim: To identify patient, carer and professional views on the concept of self-management support at 
end of life, specifically in relation to analgesia and related medicines (for side-effect management) in 
order to describe, characterise and explain self-management support in this context.   
Methodology & Methods: Qualitative design, data collection methods involved focus groups and 
interviews.  Topics included the meaning of self-management support in this context, roles and 
behaviours adopted to manage pain-related medicines, and factors that influence these.  A largely 
deductive approach was used, involving verification and validation of key frameworks from the 
literature, but with capacity for new findings to emerge.   
Setting: Participants were drawn from two different localities in England, one North, the other South.  
Interviews with patients and carers took place in their own homes and focus groups with healthcare 
professionals were held at local hospices.   
Participants: 38 individuals participated.  15 patients, in the last year of life, and 4 carers under the 
care of community-based specialist palliative care services and 19 specialist palliative care health 
professionals (predominantly community palliative care nurses). 
Findings: The concept of self-management support had salience for patients, carers and specialist 
nurses alongside some unique features, specific to the end of life context.  Specifically self-
management was identified as an ever-changing process enacted along a continuum of behaviours 
fluctuating from full to no engagement.  Disease progression, frequent changes in symptoms and side-
effects, led to a complex web of roles and behaviours, varying day by day, if not hour by hour.  Data 
confirmed previously proposed professional roles were enacted to support self-management.  
Furthermore, as patients, carers and clinical nurse specialists worked together to achieve effective 
pain management, they enacted and inter-acted in the roles of advocate, educator, facilitator, 
problem solver, communicator, goal setter, monitor and reporter.   
Conclusions: The study has demonstrated what self-management support at end of life entails and 
how it is enacted in practice.   
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WHAT IS ALREADY KNOWN ABOUT THE TOPIC? 
 Pain is a frequently reported symptom by patients who are approaching the end of their lives.  
 It is well-established patients and carers hold fears that relate to opioids, and experience side 
effects related to their use.  
 The concept of self-management support is well elaborated in the context of chronic illness  
 Through the technique of concept analysis Johnston and colleagues (2014) have defined the 
concept of self-management support from a palliative nursing perspective and outlined the range 
roles adopted by nurses to support self-management. 
 How self-management is operationalized in the practice context at the end of life remains little 
understood 
WHAT THIS PAPER ADDS 
 An empirically grounded description of self-management support at end of life, in the context of 
analgesia management from the perspective of patients, carers and healthcare professionals. 
 Characterisation of the roles undertaken by patients, carers and clinical nurse specialists to 
support opioid management and how these roles are enacted in the context of specialist palliative 
care. 
 Demonstration of the salience of the concept of self-management support as the end of life 
approaches. 
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INTRODUCTION 
Self-management support has been well elaborated and tested, and programmes of support offered 
in the context of chronic illness (Taylor et al 2014).  In contrast, in the situation where someone is 
rapidly approaching the end of life there is much less evidence of if and how this concept applies 
(Hughes et al 2016).  Johnston is one of a handful of authors to have addressed this, who along with 
colleagues (2009; 2012), argued that benefits of self-management focused symptom control include 
improved health status, reduced hospital admission, reduced pain and symptom distress, and can 
result in people feeling in more control with respect to pain and more prepared for end of life.  
Through recourse to concept analysis self-management support in palliative nursing has been defined 
as: “assessing, planning, and implementing appropriate care to enable the patient to live until they 
die and supporting the patient to be given the means to master or deal with their illness or their 
effects of their illness themselves” (Johnston et al 2014, p8).  Eight professional nursing roles that 
support self-management: advocate, educator, facilitator, problem solver, communicator, goal 
setter, monitor and reporter were outlined.  Whilst these nursing roles were depicted they were 
neither described nor characterised and little is understood about how they are operationalised in the 
context of practice. Hence there is a lack of knowledge about self-management support in the context 
of end of life care with little evidence with which to underpin practice. 
 
In one of the only studies in this area, Schumacher and colleagues in the US (2014a&b) have studied 
the self-management work that goes on in relation to pain medication management in cancer patients.  
Their research revealed that much of what goes on involves work that is challenging and frustrating 
for patients and could be alleviated by better information, skills and health services co-ordination to 
support patient self-management.  The work of getting prescriptions, obtaining medications, 
understanding, organising, storing, scheduling, remembering, and taking was perceived to be 
“unending” and required a huge amount of effort in order to navigate healthcare systems and often 
resulted in frustration and anxiety.  As the sample consisted of oncology out-patients whether these 
findings might transfer to the specific context of end of life care was not clear. 
  
Given there is limited understanding of if and how the concept of self-management support might be 
applied in the context of end of life care we set out to investigate the concept further, exploring its 
application through accessing the perspectives of patients, carers and health professionals.  We 
defined carers as anyone who cared, unpaid, for a friend or family member due to their end of life 
illness. 
 
AIMS/OBJECTIVES 
The study aimed to describe, characterise and understand the concept of self-management support 
as the end of life approaches, in the specific context of managing analgesia and related treatments.  
This work formed part of a larger study involving intervention design and a feasibility trial of self-
management support in relation to opioid medications for pain relief, and the associated side-effects 
of nausea, constipation and drowsiness at the end of life (Bennett et al 2016).  
 
The objectives were to: 
 Characterise the nature of self-management support regarding analgesia and related treatments 
at the end of life 
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 Explore in-depth the views of patients, carers and healthcare professionals regarding the 
components of self-management support in this context 
 Reveal self-management promoting behaviours and roles used by patients, carers and healthcare 
professionals  
 
METHODOLOGY & METHODS 
Study design 
A qualitative approach was used and data collection comprised focus groups and interviews, held 
within two geographical regions in England (one North and the other South).   
 
Participants 
Participants included patients, their carers and specialist, largely community based, palliative care 
health professionals (including service managers and commissioners). 
 
Sampling Strategy and Recruitment 
Inclusion criteria 
Patients were included if they were: 
1. Aged over 25 and considered (by their specialist palliative care team) to be in the last year 
of life 
2. Experiencing pain 
3. Being treated with, or starting, opioid analgesia 
4. Experiencing, or anticipating, adverse effects of nausea, constipation and drowsiness 
5. Living at home 
6. Being cared for by specialist community based palliative care services in the 2 study 
regions 
7. Had capacity to consent 
 
Carers were included if they were: 
1. The primary carer of a patient meeting the above inclusion criteria 
2. And, the patient gave consent to their involvement 
 
Healthcare professionals were included if they were: 
1. Clinical Nurse Specialists (CNSs) or doctors who were part of specialist palliative care 
teams or 
2. Service providers or managers of specialist palliative care services or 
3. Local commissioners of palliative care services 
 
In order to access a range of individuals (patients, carers and healthcare professionals) recruitment 
occurred via various strategies across four hospices and two acute Trusts.  In the Southern region 
palliative care specialist healthcare professionals at two acute Trusts and two hospices were informed 
about the study via staff meetings attended by a researcher (NC), supplemented by email invitations, 
and invited to participate in a focus group.  Patients and carers attending group sessions at two day 
hospices in the region were informed about the study by a researcher (NC) and able to ask questions 
about participation; all specified a preference for taking part in interviews (rather than a focus group).  
In the Northern region a community palliative care CNS team were invited (by MM) to take part in a 
focus group; and patients and carers were approached by a research nurse via the out-patient clinic 
at the respective hospice, and invited to a focus group.   
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Focus Group and Interview Guides  
Topic/interview guides were developed to meet the study aims.  Largely semi-structured, interview 
topics included: self-management of analgesia and related side-effects of nausea, constipation and 
drowsiness; roles played in managing medicines; processes involved in accessing, obtaining and 
understanding medicines in order to safely store, organise and take them.   Guides were constructed 
and materials used to explore and elaborate on the following concepts: 
 Definition of self-management support in the context of palliative care (Johnston et al 2014) 
 Professional roles adopted in support of self-management in the context of palliative care 
(Johnston et al 2014) 
 Processes involved in managing supply and medicines-taking encountered by patients and carers 
(Schumacher et al 2014a & 2014b) 
Interviews and focus groups were conducted by the study’s research fellows (MM & NC).  Focus groups 
took place at hospices, whilst interviews occurred in participants’ homes.  Where carers participated 
in interviews all patients expressed a wish to be interviewed with their carer (dyadic interviews).  After 
obtaining informed consent all interviews and focus groups were digitally-recorded.  Focus groups 
were conducted with a co-facilitator present, in this case another researcher with expertise in the field, 
to aid moderation (Krueger & Casey 2014). 
Data Analysis  
Audio files from the interviews and focus groups were professionally transcribed and listened to 
alongside the transcripts to check for accuracy.  Researchers (NC, MM) familiarised themselves with 
data by reading and re-reading the transcripts and identifying key issues, concepts and themes.  Initial 
coding occurred via indexing on the transcripts and each researcher summarised key themes arising 
from the data separately.  Themes were subsequently discussed for comparative purposes.  The entire 
dataset was then coded for all issues, aspects and themes relevant to self-management support (NC) 
within NVivo software (version 11).  A deductive-driven approach was used, verifying and validating 
key frameworks from the literature, but with capacity for new findings to emerge  
Ethical and Research Governance Considerations 
NHS research ethics and governance approvals were obtained from an NHS Research Ethics 
Committee (North East – Tyne & Wear South 14/NE/1155) and the respective NHS Trusts and 
independent hospices.  Written informed consent was obtained from all participants.   
 
FINDINGS 
The sample comprised 38 participants recruited across the two regions: 15 patients, 4 carers and 19 
healthcare professionals (Table 1).  The findings are presented in two discrete sections.  The first 
section characterises the range of self-management and self-management support roles adopted by 
patients, carers and nurse specialists as they relate to pain medicine management.  Secondly, these 
data are incorporated into a model of self-management support, alongside a description of the 
continuum of self-management behaviours in the context of the end of life.  
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Self-Management and Self-Management Support Roles    
Data supported the eight roles proposed by Johnston et al (2014) and furthered understanding by 
revealing the roles were not confined solely to nurses (see Table 2).  Patients, carers and CNSs enacted 
these roles in various ways (Table 2).  
 
The labels used by Johnston et al (2014) to refer to roles were presented to healthcare professionals 
during the focus groups.  They were asked for their views on these roles, whether they believed they 
occurred in practice, if anything was missing and what examples they could provide to illustrate the 
roles in action.  As a result the roles were both delineated and defined by the professionals in this 
study.   These were generated from accounts involving a preponderance of community-based 
healthcare professionals, but it could be argued the roles could equally apply to those in other practice 
settings. 
 
Descriptions from patients and carers confirmed the range and types of roles adopted and the part 
they played in managing their own or supporting the management of their relative’s opioid medication 
(and medication for nausea and constipation). The roles that patients and carers took on could be 
categorised in the same way as those undertaken by CNSs, but often implemented and enacted in 
different ways.  Some patients in the study managed their medicines almost entirely by themselves, 
however this occurred only for a minority.  Where patients had visits from a palliative care nurse 
specialist they highlighted the importance and value of their nurse input in relation to medicines 
management.  For example one patient said: “she’s the one I’m looking to for answers” (H1Pt001).  
The self-management support roles of carers fluctuated in relation to changes in the competence and 
engagement of the patient.  Some patients leant on their carers very little even where they were 
available: “he’s managed all of it very well, I’m not involved at all” (Carer-H1Pt002), but again this was 
confined to the minority.  In the case of a few patients they had always sought to hand over 
responsibility for medicines management to their carer: “she just always did it… I tend to be… not 
worried enough about it you know. I basically need looking after that’s the truth of the matter” 
(H1Pt004).    
 
To evaluate which roles were required of them, and at what point, nurses assessed the competence 
of not only the patient but also the carer.  It was recognised that self-management support roles would 
fluctuate in relation to patient and carer needs and, at times, be challenging to undertake.    
“…All of these (roles) will probably peak in difficulty, at times depending on the situation. As a 
professional, there could be a nightmare sometimes, in a person’s home advocating for that 
patient, if… you have a family who have distinct feelings that are opposing the patient, that’s 
really… difficult…” (H2HCPfocusgroup) 
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Advocate 
Patients often played an advocacy role on their own behalf, for example requesting alternative 
analgesics/opioids where they found side-effects to be unacceptable and were unable to manage 
these.   
“…I was getting really bad pains and it (morphine) didn’t seem to be controlling it.  I mentioned 
it to X who is the nurse that looks after me, and she just said “do you want me to ring Dr X or 
will you?” so I said “I’ll give her a buzz”…  You’ve got to do things…if you are able to, you’ve 
got to look after yourself quite a bit, and then know who to turn to if you can’t find the answer…” 
(H2Pt005) 
 
Where advocating on their own behalf was not possible carers took on this role for patients, especially 
when difficulties arose with challenging side-effects or poorly controlled pain.   
“…He was determined to get me into the hospice, and in the end he went over himself.  And I 
said to Sister X “I’ve got such a pushy –” and she said “that’s just what you need, you’ve got to 
have a pushy friend…” (H2Pt001) 
 
Nurses emphasised the importance of ensuring patients had the right drug, via the right route.  For 
them this was a clear example of the advocacy role: 
“…I met a lady with head and neck cancer that was really compromising her mouth and she 
was just starting on opiates, thought patch that’s going to be the best way to go… then the 
relative rings up we’ve just gone to collect the patches and it’s tablets so I’m like “Oh god” ring 
up again, “there is a reason why we said patches, I know they’re expensive but she can’t open 
her mouth…” (H2HCPfocusgroup) 
Educator 
Patients educated their carer, if they had one, regarding their medicines so if their condition changed 
or they had a bad day they could rely on them to safely administer their medications for them.  This 
often took the form of listing their medications and creating a simple timetable of what they took and 
when, and keeping this in a location in the home that could be easily referred to by others if needed.  
Equally, carers could play an educator role of both the patient and CNS via astute monitoring of side-
effects and the effectiveness of medicines, highlighting changes.   
 
The role of educator was viewed by nurses as one that involved providing “instruction and information 
regarding medicines” (H2HCPfocusgroup) to patients and carers.  This was valued strongly by patients:   
“…She (the specialist nurse) came and said “actually the reason that (medicine) is not working 
is because that works in this way” and she talked about the medication, and I just found it so, 
so helpful.  That was the first time that I felt like I’d been given a lifeline that I could just hang 
onto…” (H3Ptfocusgroup) 
The increasing role of the internet as a source of information for patients and their families was also 
recognised so that the supportive role of nurses was seen as one of helping to “refine” and apply this 
knowledge to individuals.  The need to provide education for carers specifically was recognised to be 
important as many had unmet information needs and knowledge gaps:         
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“…You get carers who the knowledge gap is so huge for them, they want to help, they want to 
know what to do and we need to be filling that knowledge gap for them appropriately… I think 
for the carer what they want is the right information and we don’t currently meet that need I 
don’t think. We try…” (H1HCPfocusgroup) 
 
To meet the informational needs of patients (and their carer) in the context of their educational role 
nurses recognised a number of key areas that needed to be addressed.  These included: 
 The starting point - working out how an individual best learns and then tailoring information to 
this.  Verbal information reinforced by written information (+ technological alternatives if possible) 
at the right pace, via step wise provision 
 Identifying types of pain and which medications are best suited for that individual 
 Outlining each medicine, what it is, what it’s for and how to take it 
 Explaining the requirement to adjust medications on an on-going basis.  Highlighting there are 
alternatives if pain remains uncontrolled or side effects are intolerable.  
 Information about side-effects – benefits vs. burdens and likelihood of an individual experiencing 
them 
 Outlining need for laxatives and working out the balance between opioid dosage and laxatives 
required 
 Revealing and discussing an individual’s fears, challenging and correcting opioid related 
preconceptions 
 Explaining lack of dosing ceilings for opioids, being clear regarding relative lack of required dosing 
intervals for ‘as required’ doses for breakthrough pain 
 Highlighting importance of monitoring effectiveness of medications (especially in relation to the 
pain experience).  Need to record breakthrough doses so that regular opioid doses can be 
increased/altered if required 
 Signposting individual and carer to contacts for concerns/questions, outlining the most suitable 
contacts for specific situations an individual may encounter  
Communicator  
The patient’s educator role aided their communicator role whereby they transferred relevant 
information regarding their medicines, their effectiveness and their experience of side-effects to 
respective healthcare professionals (particularly general practitioners and CNSs).  Carers encouraged 
communication and discussion with the patient, asking questions about whether specific medications 
were working: 
“…Every so often, I say to you don’t I “How are you on the laxatives?”  And it seems ridiculous 
doesn’t it, because… that’s the best (thing) that’s happened, that you’ve managed to get it 
(opioids + laxatives balanced) at a level which is not a problem for you…” (Carer-H2Pt004) 
 
The supportive role of communicator was seen as vital by nurses and they emphasised the 
complexities involved in communicating well and aligning this with  “the agenda of the patient” , using 
language that would be understood,  highlighting “what they need to know, because they might not 
be interested in all the things that you want to say” (H2HCPfocusgroup). 
“…I think you have to really pick your style of communication with each individual, this is what 
(participant’s name) was saying about knowing your family, knowing your patient, ‘cos 
sometimes you are as much a mediator as communicator. We can sometimes have a relative 
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that just simply doesn’t believe in morphine… they will withhold it from them… And then others 
where they will perhaps give a little too much, then you have to sort of be kind in how you say 
these things, because they want to make it better… so communication is quite hard; you have 
to get that right, don’t you…?” (H2HCPfocusgroup)  
 
Goal-setting 
For those patients who were under the care of community palliative care CNSs this often involved 
developing “joint plans”/goals with them.  Whereas patients not under the care of a CNS made their 
own plans and goals, and/or negotiated these with their general practitioner (for example coming off 
a neuropathic agent because of unacceptable side-effects).   
 
Carers often took a lead in establishing small goals for a patient when they aware these were of 
particular importance to the individual.  With effective medicines management and particularly side-
effect management, frequently goals involved getting out and about, and visiting favourite places. 
 
With respect to professional involvement in goal-setting this would often involve proposing different 
options to a patient in relation to their medicines management, allowing an individual to decide 
between different proposed courses of action and then putting a joint plan together based on an 
individual’s preferences. 
“…It’s good when you are given a choice and they say “well it’s up to you, we could do this, or 
we could do this, which would you like to try?  That is helpful…” (H3Ptfocusgroup) 
 
Facilitator 
Patients facilitated relationships with their healthcare professionals and carers so as to aid access to 
their medicines.  Patients worked at developing and maintaining relationships with those that were 
key to managing their medicines and supporting their self-management.  Generally this involved CNSs 
and general practitioners but also community pharmacists.  They often found that knowing their 
pharmacist, and the pharmacist knowing them, aided the supply and stocking of their medicines, and 
affected their ability to obtain their medicines quickly and without delays in the system.  At times 
pharmacists put in repeat prescription requests for patients because of these relationships, meaning 
a patient then just had to arrange to collect the medications from the pharmacy or they could use the 
pharmacy delivery services, where they were available.       
 
The role of specifically facilitating/managing the practical issues related to supply and medicines-
taking was frequently an onerous one for patients.  They had to get prescriptions, obtain the 
medicines, understand them once they had been dispensed, organise the medicines at home to keep 
track of them, store them, schedule them around their routine, remember to take them and finally 
actually administer them.   
“…I’ve had problems between the Chemist and the GP… one saying it’s the other one’s 
responsibility, and the other one saying it’s the other.  Nobody will take an overall responsibility 
for it (repeat supply), either prescribing it to the Chemist and then the Chemist gives it to me, 
or have I got to do it myself, or can they ring up and do it?  And that’s a kind of constant thing 
that’s carried on…” (H3Ptfocusgroup) 
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The implications of the supply system and the requirements for organising, storing, scheduling, 
remembering and administering were very significant in patient and carer accounts and Table 3 
summarises the effects and impact of these issues (Table 3).  
Carers facilitated the supply system by managing all the practical issues of: getting prescriptions, 
obtaining the medicines, understanding the medicines, organising the medicines in the home 
environment to keep stock of them, storing them safely, scheduling them around the patient’s routine, 
remembering (i.e. reminding the individual to take the medicines) and administering medicines if 
required (Table 3):   
“…I have a friend who does my patches for me.  And between us, there is both of us to 
remember which night it is to change it and which it isn’t…” (H3Ptfocusgroup) 
Facilitating on behalf of the patient in relation to obtaining medicines was complex, onerous and a 
hugely time-consuming process for many carers.  Carers also pre-emptively facilitated stock 
management, requesting medicines before they ran out, and chased both GP practices for 
prescriptions and pharmacies if medications had not been dispensed as requested. 
One patient outlined his difficulties (lengthy delays) in obtaining supplies of his fentanyl patches 
through a non-palliative care specialist pharmacy.   
“…When I rang through (to the pharmacy) and said “Here look, what about these patches?  
And the woman said “What are they?”…  She said “Yes, well we have got them down on the 
list, but I don’t know where they are”.  On like that again…” (H2Pt004) 
This left his wife needing to make in person visits to the pharmacy, striving to facilitate supply on his 
behalf, only for her to be equally frustrated and leave without the patches in tears because she could 
not answer the question of “who’s prescribed this?” (Carer-H2Pt004). 
Nurses also acted as facilitators in relation to the practical issues of getting prescriptions, obtaining 
the medicines, organising the medicines at home, storing the medicines safely and scheduling the 
medicines around their daily routines (Table 3).  For example:  
“…Getting prescriptions… we spend a lot of our time trying to sort that out, and you can 
understand how patients really struggle with (it). I mean one chap… it has taken so many 
phone calls and so much of my time… a youngish intelligent chap and he has just really 
struggled with that. I think the other issue is sometimes they get 28 tablets and then you 
change them, then that knocks their whole sort of repeat prescription out of balance…” 
(H1HCPfocusgroup) 
 
This was a time consuming role for nurses as medication supplies often got “out of sync” for patients 
with alterations in a prescription.  For example, doubling a dose then meant that supplies lasted for 
much shorter periods of time and ran out in advance of supplies of other medications.   
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Problem-Solver 
Patients played a problem-solving role, often striving to navigate the difficulties posed by the 
medicines supply system.  They also problem-solved the side-effects of their opioids making decisions 
to appropriately balance the benefits of pain control vs. a manageable level of side-effects for them 
personally.  This was always a balance, for example titrating laxatives or anti-emetics on a daily basis 
to offset the common side-effects.  Some individuals, whilst in the minority, made decisions regarding 
which dose of opioid to take, where a range has been prescribed from which they could choose.   
 
The role of carer in relation to problem-solver was an influential one.  In the words of one carer “I try 
and stop problems happening” (Carer-H2Pt004).  This was in the main pre-emptive, resolving potential 
problems before they arose.  This was particularly the case in terms of asking an individual about their 
pain, so as to be able to suggest and administer ‘as required’ analgesia.   
 
Within their problem-solving role nurses sought to work out the best drug and dosage with the most 
tolerable side-effect profile for an individual, recognising that this necessitated fine-tuning over time, 
time which was by its very nature limited at the end of life.  This problem-solving role was frequently 
implemented in a pre-emptive way, and referred to as “mind-reading” or being “a problem solver in 
advance”, necessitating always having “a plan B” (such as knowing when and who to contact or the 
likelihood of a particular individual experiencing a crisis episode e.g. chest inflections or bowel 
obstruction and conveying information to support patient and carer recognition).   
“…You’re anticipating, you’re pre-empting what might happen to be able to talk it through 
with that patient and to that carer to be able to give them you know a toolkit of who to ring, 
when to ring and why they might ring. How to deal with the uncertainties of do I ring now, do 
I ring later… the security of knowing that there is somebody to ring…” (H1HCPfocusgroup) 
 
 
Monitor 
Patients monitored their symptoms, side-effects and the effectiveness of their medicines, often 
keeping their own records of this, particularly in relation to administration of ‘as required’ doses for 
breakthrough pain.  This was often facilitated through the input of community palliative care CNSs or 
general practitioners who prompted patients to consider “how much they were taking, when they 
were taking it, and how did they find it?” (H2HCPfocusgroup).   
 
Carers often played a monitoring role highlighting and watching for condition changes, symptom 
changes and alterations in side-effect management.  Indeed, the monitoring they undertook was often 
extremely astute due to the fact they were the person who knew the patient best.   
The CNS role of monitor was closely related in practice with the role of goal setter (involvement in 
decision-making and shared responsibility where possible).  Nurses continually monitored “how much 
the patient has understood”: 
“…In terms of monitoring… it’s about involving the patient in those decisions isn’t it… having 
given them some education… when you’re reviewing things… saying to them “So are you happy 
then that we’re still on the same dose for now?”… They’ve got that involvement in that… it’s 
like an agreed shared sort of responsibility…” (H1HCPfocusgroup)  
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This monitoring role was seen as an imperative professional responsibility, particularly when starting 
individuals on new medications.  This led nurses to frequently contact patients, either face to face or 
on the phone, often within 24 hours of starting a new drug.  Nurses emphasised the value of face-to-
face monitoring in the context of end of life.  In the words of one:  
“…It’s a blended approach really, you know, just to phone them up, say “How are you doing?” 
and if you sense that… the things you are listening to aren’t representative of somebody 
managing, then you actually go back and reassess them face-to-face; there is nothing quite 
like eyeballing a patient..!” (HCPW001) 
 
 
Reporter 
As a result of the monitoring role patients undertook they were often in a position to accurately report 
their relevant symptom and side-effect experiences, and changes, to their healthcare professionals.  
Carers often aided monitoring of the effectiveness of the medicines by asking simple questions such 
as: “Is it helping? Does that help?”  Consequently, carers encouraged discussion with the patient 
(within their communicator role) and could report this information to healthcare professionals.  In 
addition, CNSs often relayed and discussed goal-setting plans with the wider palliative care team and 
general practitioners (to support medication changes) under the role of reporter.   
 
Continuum of Self-Management Behaviours 
Further inductive analysis led us to generate a model of self-management support pertinent to the 
end of life context (Figure 1).   
Self-management support was conceived as a dynamic process, enacted through a continuum of 
behaviours and depended on the specific responsibilities and roles adopted by patients, carers and 
specialist nurses.  This is context specific (end of life) and influenced by opioid-related fears.   
 
At the centre of the model (Figure 1) is a continuum of behaviours that ranged from: 
 Full engagement - with full responsibility chosen by an individual, with acceptance of the 
possibility of risk and requirements for complex decision-making, through to  
 No Engagement -  with reduced capabilities and willingness to engage in self-management 
behaviours, for example through individual choice (preference), the effects of uncontrolled pain, 
the side-effects of opioids (particularly drowsiness), clinical depression and memory loss, all of 
which lead to responsibilities being transferred to another (the carer and/or CNS) 
Study participants highlighted variation in the range of self-management behaviours enacted.    
“…You’ll get some who don’t want anything to do with their medicines…. and then people that 
want to know everything will… do their own thing as much as they can…” (H1HCPfocusgroup)  
 
“…Asking them to go through their medicines, some people haven’t got a clue, and other 
people don’t even need to get the boxes or list out and they can tell you absolutely everything 
they’ve had …” (H4HCPfocusgroup) 
 
When discussing the role patients’ played in managing their medicines those who felt in control, often 
referred to how “lucky” they were in terms of being able to “think about it and work it out”.  These 
individuals accepted and preferred full responsibility and were “doing it all” themselves, but with 
backup strategies in place and knowledge of whom to contact should issues arise.  
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Healthcare professionals often spoke about individuals who were at polar ends of the continuum, but 
there was also evidence of wide intra-person variation in both behaviours and choices and these could 
and did continually fluctuate: 
“…A man that’s really angry and frustrated, he’s young but he was diagnosed late. He’s had 
lots of frustrations with chemo, and things like that. So he’s quite resistant to changes, and 
that’s fine, so we’ve just left him (medication wise) as he is; he’s not managed quite properly, 
not adequately in our eyes, but he is doing what he wants to do at the moment…” 
(H4HCPfocusgroup)  
The degree of competency and degree of engagement in tasks involved, and preference in regard to 
accepting responsibility affected patients’ enactment of self-management behaviours, and 
subsequently influenced the roles adopted by carers and CNSs.  Nurses recognised the importance of 
assessing an individual’s capabilities – and their potential for engagement (what the individual was 
currently doing vs. what they would like and had capacity to do).   
 
End of Life Context 
The fact patients were approaching the very end of their lives had a profound influence on the 
supportive self-management behaviours of patients, carer and CNSs.  Continual disease progression 
led to rapid changes in symptoms and side-effects experienced from medication and treatment.  This 
in turn led to fluctuations in behaviours.  This context was overlaid with individuals and their families 
striving to deal with the psychological distress and high levels of carer strain that can accompany 
terminal decline.  
“…So we started in January last year (date of palliative diagnosis). I’ve aged. Well, somebody 
asked me (my age) the other day, I said “I’m 95 next week!” they didn’t argue (actual age 80), 
they could see I probably was!  I crawl up the stairs some nights…And I’m gradually running 
out of energy; completely…” (Carer–H2Pt004) 
 
Individuals could be struggling to cope with a palliative diagnosis, and anxiety and clinical depression 
could be present in one or both patients and/or carers.   
 “…When I got very depressed, I had flu and (participant’s name) was ill with his pleurisy thing 
and I, we were both very poorly and I got exceptionally depressed and wanted some help…  
The thing is that if I’m not well it affects (participant’s name) and so I felt doubly bad…” (Carer–
H1Pt002)  
 
As a result, the self-management capabilities of patient and carer could fluctuate greatly, and this in 
turn influenced the supportive self-management roles adopted by the CNS. 
 “…I have very clear memories of a lady being very competent and able with her medication, 
and then her disease progressed. And I arrived one day to see that she’d put all her tablets on 
to a tray, and mixed them, they looked like dolly mixtures. Because her condition had 
deteriorated so badly and because then she took the wrong medications at the wrong time, it 
exacerbated her condition. So it’s that fine balance of monitoring, empowering people, giving 
them the information but actually responding very quickly when you see that things have 
changed, their abilities have changed. And this can be so with a carer. Because carers’ 
conditions don’t remain static…” (HCPW001) 
 
 
Opioid-Related Fears 
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Patient and carer behaviours in relation to opioid management were strongly affected by 
misconceptions such as: fear of addiction “you hear of so many people get(ting) addicted to certain 
things” (H1Pt004); assumption that there is a ceiling dose for opioids as with other medicines; fear of 
over-dosing; fear that these medicines are “killers” (H2HCPfocusgroup); assumption that the 
individual will develop a level of tolerance; fear that death of the individual is imminent i.e. “I’m dying” 
(H1HCPfocusgroup); and fear that in taking these medicines now then there is “nothing later… so I’ll 
avoid it if I can” (H1HCPfocusgroup).  Nevertheless, the most common fears related to opioids were 
about side-effects.   
“…The greatest fears are not so much the addiction but sedation or constipation and again it’s 
a reluctance, “I won’t take it unless I need to ‘cos I don’t want those effects…” 
(H1HCPfocusgroup)  
Patients were reluctant to take opioids for fear of both constipation and drowsiness. The fear of 
constipation and subsequent difficulties in balancing doses of laxatives with opioid intake was 
particularly troublesome for some.  Some had experienced faecal impaction requiring hospice 
admission; as a result the fear of constipation was profound.   
H2Pt004: My main concern is that if I get some pain, I take extra morphine. I’m on a patch at 
the moment, so if I change the dose of the morphine, I have to change the dose that I take of 
the laxative. And of course, the first time “oh yeah, ok, let’s bang it up by another one of the 
sachets”. And of course I was then for the next two days on the loo! So “oh let’s cut it down”, 
by which time “Oh god I haven’t been to the loo now for two days!”  
Carer: I’ve never before seen people so frightened of constipation, as he has been.  
  
 
DISCUSSION  
The majority of end-of-life care takes place in the home, being undertaken by patients and carers and 
supported by health care professionals, often nurses.  Effective management of medicines in this 
context is critical for symptom control, quality of life, avoidance of unplanned and emergency services 
and hospital admission.  Equipping and supporting patients and carers to self-manage this important 
task is a key nursing responsibility.  Yet little was known about how self-management is enacted in the 
home setting at the end of life.  To our knowledge, this is the first UK study to characterise self-
management and how it is supported in this context, providing a valuable understanding of the work 
and roles that patients and carers undertake and how nurses can and do support this. 
Our findings highlight the variety of roles that nurses enact to support patients and carers self-
managing medicines, and they confirm and embellish the role typology proposed by Johnston et al 
(2012).  Additionally, we also discovered that patients and carers may assume these roles in pursuit 
of self-managing medicines, albeit with slightly different foci than that taken by the nurses.  For 
example, the need to sometimes act as advocate, facilitator and reporter was common to all actors in 
this context.  This also highlights the significant work that patients and carers were found to be 
undertaking in order to effectively self-manage.  Similar to the context of long-term conditions (see 
Boger et al 2015), self-management here did not comprise patients and carers managing with 
complete autonomy however, but required a blend of autonomy balanced with input and support 
from health care professionals.  The finding that self-management support in the end-of-life context 
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involves the provision of information and education also chimes with key factors identified as 
necessary for self-management in other contexts (Taylor et al 2014). 
The idea of self-management being a dynamic process, with shifts in patient preference for taking 
responsibility versus being a more passive recipient of care is not new.  Brearley (1990) first proposed 
that patient participation in care will vary according to factors including acuity of illness and age.  
Protheroe et al (2008) also found that patients with long-term conditions need information for self-
management at different stages in their illness trajectory and in a variety of formats, depending on 
the receptivity of the patient.  However, what our findings indicate is that this inter- and intra-personal 
fluctuation also exists in the end of life context, and indeed is compressed and magnified due to the 
complex context in which self-management is enacted and supported.  The end of life context, 
characterised by often rapid disease progression, difficult psychological states, medicines’ side-effects 
and opioid-related fears, all contributed to the existence of a continuum of self-management 
behaviours ranging from full to limited or no engagement, and rapid changes in patient and carer 
competencies in, and preferences for, self-management.  This is in contrast to long-term conditions 
such as diabetes or asthma, which, if well controlled, offer more stable conditions for supporting self-
management over a longer period of time. 
The study findings illustrate that effective nursing support for self-management in this context 
requires highly skilled, individualised and on-going assessment of patient and carer needs to detect 
changes in competencies and preferences for engagement and responsibility.  Nurses must also adapt 
and assume roles that shift and complement these changing patient and carer competencies and 
preferences.  The salience of opioid-related fears, in addition to frequent changes in medicines and 
polypharmacy, means that a key feature of self-management support is provision of information and 
education to allay fears, change misconceptions and enhance understanding of medicines’ actions and 
side-effects.  Together with experiences from previous research (Latter et al, under review), we used 
our identification of these central components of self-management support (assessment and 
education), along with goal-setting, monitoring and coaching to form the basis of an end-of-life 
analgesia and related treatments self-management support intervention delivered by nurses and 
tested in a feasibility trial (see Bennett et al 2016). 
Finally, our findings identify the often-problematic issues that accompanied patients’ and carers’ 
experiences of medicines supply and medicines-taking.  Our data confirmed that of Schumacher et al’s 
(2014 a&b) study – that these processes exist in a UK context and are typically characterised by effort 
and burden for the patient and carer.  Additionally, we suggest that many of the problems - such as 
those described in ‘getting’ and ‘obtaining’ medicines in Table 3 - are due to system or service 
organisation failure.  For example, the dearth of nurse prescribing in palliative care has been noted 
elsewhere (Zeigler et al, under review) and appears to contribute to patients’ experience of delayed 
access to medicines.  Community pharmacy services might also require improvement, and new 
services in the UK such as community pharmacist palliative care medicines access services may be 
important in redressing the problems patients and carers experienced in our study.  Further research 
is needed into patient and carer experience of accessing medicines in the end-of-life context. 
 
CONCLUSION: 
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Our study has demonstrated for the first time what self-management support at end of life entails and 
how it is enacted in practice, in relation to analgesia and related treatments.  The concept has 
highlighted the importance for specialist nurses of recognising the roles that patients and carers play, 
alongside their own, and the factors that impinge on them.  Skilled on-going assessment is central to 
this, as well as the requirement for the specialist nurse to adjust his or her own roles and behaviours 
in line with this assessment, as preference and capability fluctuate. 
Self-management support was enacted on a continuum of self-management behaviours.  The 
enactment of behaviours was dependent upon where the interpretation of responsibility lay.  This 
required an assessment (by the healthcare professional) of competencies held by the patient and 
carer.  It was also dependent upon the acceptance (or not) of choice by the individual patient and/or 
carer, as well as the acceptance (or not) of risk by these individuals, and a degree of transfer of risk 
from the professional. 
“…I think it’s about accepting that patients do things the way they want to…, it’s their journey… 
that they are going on, and it’s not up to us to dominate… I’ll often have that conversation… 
“They did it their way didn’t they? It may not have been the way we’d have done it, but it’s 
what worked for them…” (H4HCPfocusgroup) 
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Figure I – Conceptual Model of Self-Management Support of Analgesia and Related Treatments at the End of Life 
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Table 1: The sample 
Patient and Carer Sample 
Northern region 
 
1 focus group  
n=4 patients 
Southern region 
 
11 interviews  
n=11 patients 
n=4 carers 
Total 19 patients + carers 
Healthcare Professional Sample 
Northern region 
 
1 focus group  
n=4 clinical nurse specialists 
1 face to face interview  
n=1 consultant 
Southern region 
 
2 focus groups 
n= 10: 9 clinical nurse specialists + 1 specialist registrar 
n= 3:  2 in-patient unit nurses, +1 lecturer/practitioner 
1 telephone interview  
n=1 lead nurse/commissioner 
Total  19 healthcare professionals 
Overall sample total 38 participants 
Healthcare Professional Demographics 
Gender Female n=18 
Male n=1 
Professional background Nursing n=17 
Medicine n=2 
Main working environment Hospice in-patient n=4 
Hospice education n=1 
Community n=10 
Hospital n=2 
Community and day hospice n=1 
Hospital, hospice + community n=1 
Length of time in current post Range 6 months - 24 years 
Mean 7 years 
Length of time in palliative 
care specialism 
Range 1 year - 27 years 
Mean 13 years 
Patient Demographics 
Gender Male n=8 
Female n=7 
Age Range 47 - 84 
Mean age 66 
Cancer site Bile duct, Breast, Colon, Lung n=3, Melanoma, Mesothelioma, 
Oesophagus, Pancreas, Prostate n=2, Uterus 
Educational level  Degree level or above n=4 
Below degree level n=6 
No qualifications n=5 
Carer Demographics 
Gender Female n=4 
Age Range 52 – 80  
Mean age 69 
Educational level Degree level or above n=2 
Below degree level n=2 
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Table 2 – Self-management and self-management support roles adopted by patients, carers and nurse 
specialists  
Roles Patient  Carer Clinical Nurse Specialist 
Advocate For themselves e.g. 
requesting alternative 
opioids/forms if side-
effects are not acceptable 
Total advocacy role 
where needed 
Ensuring patients receive 
appropriate medicines to meet 
their symptom control needs 
 
Educator Of carer if required, 
anticipation of future 
changes (i.e. planning for 
worsening condition) 
Of patient and clinical 
nurse specialist where 
needed 
Refining knowledge for 
individuals, providing 
instruction 
Facilitator Of relationships (GP, 
healthcare professionals 
and carer, carer and 
community pharmacist) 
and access to medicines  
Manager of the practical 
issues e.g. storing, 
organising and 
administering medicines, 
where needed 
Assisting with the practical 
issues e.g. storing, organising 
and administering medicines  as 
needed 
Problem-
Solver 
Access to medicines and 
navigating the supply 
system, side-effects 
management and off-
setting doses 
Pre-emptive, for example 
regarding stock 
management or 
suggesting need for 
breakthrough analgesia 
Best drug and side-effect profile 
for individual, sorting out when 
supplies get in a muddle, pre-
emptive problem solving 
Communicator Of relevant information to 
all – family and health care 
professionals 
Encouraging discussion 
with patient 
Selecting the style of 
communication for individual, 
knowing the family and patient 
(mediator as well as 
communicator) 
Goal-Setter Self-planning, planning 
with a GP or joint planning 
with clinical nurse 
specialist 
Often in relation to 
getting out and about 
e.g. getting out of the 
house for a coffee, going 
to a favourite place 
Proposing options and allowing 
the individual to decide what 
they would prefer and putting a 
plan together 
Monitor Writing down of 
breakthrough doses and 
noting effectiveness 
Pain diary recording Assessing how much 
information has been 
understood.  Monitoring 
involvement of patient in 
decisions and reviewing 
effectiveness of medicines 
Reporter Of relevant symptom 
experiences and side-
effects 
Evaluation of 
effectiveness of 
medications 
To wider palliative care team 
and GPs 
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Table 3 – Summary of difficulties and impact of issues with medicine supply and taking 
Medicines Supply and 
Taking Steps 1 
Specific Difficulties Impact 
Getting 
prescriptions  
 New - initial 
prescriptions 
and changes to 
prescriptions 
 Repeat 
prescriptions 
Few clinical nurse specialists 
independent prescribers 
Common requirement for patient to 
make an appointment with GP to gain 
new prescription (not all had the input of 
a CNS who could contact the GP on their 
behalf) 
Frequency of need for new 
prescriptions due to fine-tuning of 
pain medicines to meet changing 
needs 
Time consuming process gaining new 
prescriptions 
Prescribing by different specialists Patients/carers may not know who 
prescribed the medication and where 
this is queried by dispenser supplies may 
not be dispensed 
Need to physically collect 
prescription due to legal 
requirement for opioid prescription 
to be collected 
Patient/carer asked to collect 
prescription from GP surgery, unless the 
GP practice and the pharmacist are 
willing and able to transfer the 
prescription electronically 
Lack of syncing of supplies - one 
medicine may last for two weeks or 
less, others for longer 
Frequency of need for some repeat 
prescriptions.  Need for request of some 
medicines but not others, often others 
are dispensed causing potential waste 
and costs.  Difficulties with online GP 
practice systems for repeat prescriptions 
– slow and unstable platforms 
Obtaining medicines Having to get to the pharmacy 
 
Carer or someone else having to go on 
individual’s behalf, who may not know 
what should be dispensed 
Pharmacies offering a delivery 
service   
Requirement to wait in to sign for 
receipt of the delivery 
Patients tend to use the nearest 
pharmacy rather than one that may 
be a ‘palliative care specialist’ 
pharmacy and more likely to stock 
these medicines  
Delay in dispensing the prescription as 
the pharmacy may not stock the 
medicine or the prescribed dose 
Need to establish a relationship 
with the pharmacist 
Patients encountered having to establish 
new relationships with pharmacists 
when there were changes in 
management 
Possibility of dispensing errors 
 
Patients encountered medicines being 
dispensed that had not been requested, 
ones that had been requested could be 
missing or in a form not expected e.g. 
tablets rather than capsules 
                                                          
1 After Schumacher, K. L., Plano Clark, V. L., West, C. M., Dodd, M. J., Rabow, M. W. & Miaskowski, C. (2014). 
Pain medication management processes used by oncology outpatients and family caregivers part I: health 
systems contexts and part II: home and lifestyle contexts. Journal of Pain and Symptom Management, 48(5), 
770-96. 
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Understanding Individuals are faced with 
understanding the medicines once 
collected 
Lack of understanding can result in 
uncontrolled pain and poor side-effect 
control of nausea and constipation 
Individuals usually receive 
information about their medicines 
but this may not be to the extent 
needed or in a helpful form or may 
not be retained 
alternative forms required to backup 
initial verbal information-giving 
Confusion due to medicines with 
similar sounding names, 
abbreviations, maximum dose limits 
and intervals between taking 
medicines 
Commonality of fears based on the 
misconception that opioids have dose 
ceilings and misconceptions about 
dosing intervals for breakthrough (as 
required) opioids 
Medicines may be recognised by 
their appearance rather than name, 
and pet names for the medicines 
may be used  
Exacerbates difficulties in gaining repeat 
prescriptions – patients may be reliant 
on GP practice online systems 
recognising what they have previously 
requested 
Information printed on labels may 
be too small; lack of awareness 
even from specialists that the labels 
can be printed in larger font 
Patients and carers unable to read 
labels, leading to confusion and / or lack 
of understanding? 
Wide range of potential information 
sources – GPs, nurses, pharmacists, 
the package inserts, the internet 
etc. 
Patients did not report any 
contradictions in information given from 
the various sources but they reported 
fears being generated from the package 
inserts and the internet 
Organising Number and various forms of 
medicines prescribed within 
analgesic regimes (for regular and 
as needed use), including patches 
and liquids as well as pills precludes 
orderly arrangement 
Orderly arrangement of numerous and 
various medicines at home can be 
difficult for many, preventing medicines 
from being easily remembered and kept 
track of 
Requires individuals to set up their 
own organisational strategies e.g. 
plastic boxes/tubs, cupboards, 
stacks of drawers 
Wide range of individual strategies are 
used, which are not always orderly to 
allow stock levels to be monitored etc. 
Filling of a dosette box; lack of 
clarity for patients about who does 
this and which medicines can go in 
it.  With supplies of pharmacy-filled 
dosette boxes e.g. NOMAD, the 
usual arrangement made is for 
opioids not to be dispensed in the 
boxes because of the likelihood of 
prescription changes 
Where individuals purchase a dosette 
box and self-fill it they may not know 
which medications are suitable to be 
stored in it.  Individuals have to 
remember to take their opioids in 
addition to the medicines in their 
dosette box.    
 
Storing Need to put medicines safely away, 
particularly from grandchildren; 
safe storage is often not addressed 
by specialists 
Medications are not always stored in the 
safest location e.g. difficulties in shared 
accommodation 
Storage of ‘old’ medicines; many 
had relatively large supplies of out-
dated (but not expired) prescription 
medications 
These stores can add to the complexity 
for patients and they may not be able to 
return them to a pharmacy for disposal 
Scheduling Scheduling medicines according to 
the best time to take them in 
Patients may need help to do this, but 
few patients had been aided by a 
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relation to an individual’s daily 
routine 
medication chart that had been drawn 
up for them by their clinical nurse 
specialist 
Requires understanding of which 
medicines provide maximum 
benefit with a fixed schedule and 
which can be tailored to changing 
needs 
This level of understanding may develop 
over time but for others medications are 
seen as something that requires a fixed 
schedule.  Some may link their schedule 
to mealtimes, others at easy to 
remember times e.g. 8am and 8pm 
meaning medicines may not always be 
administered at appropriate times? 
Remembering Remembering to take the pills 
 
Often complicated by a mind-set of 
taking medicine only when the symptom 
is present.  Problems arise particularly 
when daily routines change e.g. with 
visitors or trips out of the house.  
Drowsiness, fatigue and memory loss 
exacerbate difficulties leading to 
medicines not being taken and 
questioning of whether they have been 
taken already 
Carers may be required to play a 
key role in reminding individuals to 
take their medicines 
Some may use alarms to remind 
themselves to take their medicines 
Taking Nausea makes taking medicines 
problematic 
Need for prophylactic anti-emetics 
where nausea is an issue 
There may be trouble swallowing 
large pills or opening tamper proof 
medicine bottles/filling syringes etc. 
Particular difficulties noted with the 
use of syringes for small doses of 
liquid opioids.  Syringes not 
supplied routinely by pharmacies 
and on repeated use the markings 
may wear off 
Medicines-taking a difficult experience 
for some. 
Potential for less than adequate 
symptom control 
Often requirements change, 
requiring review. 
Are the medicines being dispensed 
in the most suitable form and route 
for the individual?   
Lack of review may lead to appropriate 
forms and routes of medicines, resulting 
in less than adequate medicine –taking 
and poorly controlled symptoms 
 
 
 
 
